DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Collaborative Tinnitus Research at Washington University

Phase 2

Completed

Conditions: Subjective Tinnitus

Interventions: Device: rTMS

First Posted Date: 2007-12-05

Last Posted Date: 2018-11-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 55

Registration Number: NCT00567892

Locations: 🇺🇸
Washington University Medical Center, Saint Louis, Missouri, United States

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Not Applicable

Terminated

Conditions: Postmenopausal Syndrome

Interventions: Drug: Estrogen
Drug: Placebo
Drug: Progesterone

First Posted Date: 2007-11-30

Last Posted Date: 2018-10-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 22

Registration Number: NCT00565916

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1

Completed

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: sunitinib and rapamycin (Drug will be held)

First Posted Date: 2007-11-08

Last Posted Date: 2016-05-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT00555256

Locations: 🇺🇸
Washington University School of medicine, St. Louis, Missouri, United States

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

Not Applicable

Completed

Conditions: Insulin Resistance
Body Composition

Interventions: Drug: Depakote (valproate)

First Posted Date: 2007-11-02

Last Posted Date: 2018-06-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 120

Registration Number: NCT00552500

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

The Impact of an Antimicrobial Utilization Program on Antimicrobial Use

Not Applicable

Completed

Conditions: Antimicrobial Prescribing Practices

Interventions: Behavioral: Academic Detailing by the Antimicrobial Utilization Team (AUT)

First Posted Date: 2007-11-02

Last Posted Date: 2007-11-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 785

Registration Number: NCT00552838

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients

Phase 4

Completed

Conditions: Catheter Related Bloodstream Infection

Interventions: Device: Chlorhexidine-impregnated foam dressing

First Posted Date: 2007-10-30

Last Posted Date: 2007-10-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 121

Registration Number: NCT00550693

Locations: 🇺🇸
Barnes-Jewish Dialysis Center, Saint Louis, Missouri, United States
🇺🇸
Chromalloy American Kidney Center, Saint Louis, Missouri, United States

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Phase 2

Completed

Conditions: Cervical Cancer

Interventions: Drug: Topotecan
Drug: Cisplatin
Drug: Bevacizumab

First Posted Date: 2007-10-24

Last Posted Date: 2014-08-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT00548418

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States
🇺🇸
The Ohio State University College of Medicine, Columbus, Ohio, United States

Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)

Phase 4

Completed

Conditions: Catheter-related Bloodstream Infection

Interventions: Device: Chlorhexidine-impregnated foam dressing

First Posted Date: 2007-10-23

Last Posted Date: 2013-09-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1088

Registration Number: NCT00548132

Locations: 🇺🇸
Barnes- Jewish Hospital, Saint Louis, Missouri, United States

Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities

Phase 2

Completed

Conditions: Leukemia, Myeloid, Acute

Interventions: Drug: Lenalidomide

First Posted Date: 2007-10-19

Last Posted Date: 2014-09-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT00546897

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

Not Applicable

Completed

Conditions: Otitis Media With Effusion

Interventions: Drug: lansoprazole
Drug: placebo

First Posted Date: 2007-10-18

Last Posted Date: 2018-06-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT00546117

Locations: 🇺🇸
St. Louis Children's Hospital, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy